a public good project by the
Synthesis
Company
of California

© 2026

Ryu Yanagisawa | doi.page

0 works0 citations0 h-index

Ryu Yanagisawa

Shinshu University(JP)Shinshu University Hospital(JP)

Publications by Year

Research Areas

Hematopoietic Stem Cell Transplantation, Immune Cell Function and Interaction, Acute Myeloid Leukemia Research, Blood transfusion and management, Autoimmune and Inflammatory Disorders Research

Most-Cited Works

→ Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections(2012)248 cited
→ Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor(2014)183 cited
→ Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations(2007)161 cited
→ Clinical Significance of Cloned Expansion and CD5 Down‐Regulation in Epstein‐Barr Virus (EBV)–Infected CD8+T Lymphocytes in EBV‐Associated Hemophagocytic Lymphohistiocytosis(2010)65 cited
→ WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study(2018)64 cited
→ Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan(2018)57 cited

→ Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia(2010)

49 cited

→ Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome–positive acute lymphoblastic leukemia(2014)46 cited

→ Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1–specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature(2014)42 cited

→ Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells(2007)35 cited